Interleukin-1-mediated inhibition of cytomegalovirus replication is due to increased IFN-beta production.

Publication Type:

Journal Article


Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, Volume 22, Issue 7, p.765-72 (2002)


Antiviral Agents, Bone Marrow, CYTOMEGALOVIRUS, Fibroblasts, Humans, Interferon-beta, Interleukin-1, Recombinant Proteins, Stromal Cells, Virus Replication


Previous studies have demonstrated that the intercellular spread of cytomegalovirus (CMV) is reduced in marrow stromal cells that either secrete interleukin-1 (IL-1) or are treated with exogenous IL-1. Here, we report that IL-1-treated marrow stromal cells and fibroblasts, when infected with CMV, produce decreased amounts of infectious progeny virus. CMV-infected cells treated with IL-1 contained more interferon-beta (IFN-beta) mRNA at 24 h postinfection compared with untreated, infected cells. IFN-beta protein secreted into fibroblast culture supernatants increased from 46 +/- 1 IU/ml in untreated, infected cells to 116 +/- 5 IU/ml in IL-1-treated infected cells. When IFN-beta activity was inhibited, using blocking antibodies to either the cytokine or the IFN-alpha/beta receptor, the addition of IL-1 no longer limited viral spread. Furthermore, viral spread in nonIL-1-treated cultures was inhibited by the addition of recombinant IFN-beta. These studies suggest that IL-1 functions to limit CMV spread by increasing the expression of IFN-beta, which in turn reduces production of infectious virus.